Literature DB >> 18703569

Intraductal papillary mucinous neoplasms of the pancreas: clinical and pathological features and diagnostic approach.

N Katabi1, D S Klimstra.   

Abstract

Pancreatic intraductal papillary mucinous neoplasms (IPMNs) are mucin-producing neoplasms with a frequent papillary architecture that arise within the pancreatic ducts and are increasingly being recognised. Because they exhibit a spectrum of dysplasia ranging from low grade to high grade and may also have associated invasive carcinoma, and because they are clinically detectable, they are now intensively studied. There is marked overlap between IPMNs and pancreatic intraepithelial neoplasia (PanIN), such that the distinction between these two lesions is nearly impossible in certain cases. In addition, IPMNs sometimes can be confused with other primary cystic lesions of the pancreas. As a result, the correct diagnosis of IPMN can be challenging. This review addresses the clinical and pathological features of IPMNs, emphasising their diagnostic criteria, differential diagnosis and biological behaviour. Problematic issues in the pathological evaluation of IPMNs are discussed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18703569     DOI: 10.1136/jcp.2007.049361

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  15 in total

1.  A 71-year-old man with a large cystic pancreatic mass.

Authors:  Deborah Mukherji; Walid Faraj; Mohamed Khalife; Ali Shamseddine; Nadim El Majzoub; Ghazi Zaatari; Manish Shah; Ghassan K Abou-Alfa; Eileen M O'Reilly
Journal:  Gastrointest Cancer Res       Date:  2012-01

2.  Human pancreatic cancer fusion 2 (HPC2) 1-B3: a novel monoclonal antibody to screen for pancreatic ductal dysplasia.

Authors:  Terry K Morgan; Karin Hardiman; Christopher L Corless; Sandra L White; Robert Bonnah; Henry Van de Vrugt; Brett C Sheppard; Markus Grompe; Ediz F Cosar; Philip R Streeter
Journal:  Cancer Cytopathol       Date:  2012-07-18       Impact factor: 5.284

Review 3.  The secret origins and surprising fates of pancreas tumors.

Authors:  Jennifer M Bailey; Kathleen E DelGiorno; Howard C Crawford
Journal:  Carcinogenesis       Date:  2014-02-28       Impact factor: 4.944

4.  Interobserver agreement for detection of malignant features of intraductal papillary mucinous neoplasms of the pancreas on MDCT.

Authors:  Richard K G Do; Seth S Katz; Marc J Gollub; Jian Li; Jennifer LaFemina; Emily C Zabor; Chaya S Moskowitz; David S Klimstra; Peter J Allen
Journal:  AJR Am J Roentgenol       Date:  2014-11       Impact factor: 3.959

5.  Trefoil factor 1 inhibits epithelial-mesenchymal transition of pancreatic intraepithelial neoplasm.

Authors:  Junpei Yamaguchi; Yukihiro Yokoyama; Toshio Kokuryo; Tomoki Ebata; Atsushi Enomoto; Masato Nagino
Journal:  J Clin Invest       Date:  2018-07-23       Impact factor: 14.808

6.  Imaging comparison of tubular and colloid pancreatic adenocarcinoma arising from intraductal papillary mucinous neoplasm on multidetector CT.

Authors:  Joanna G Escalon; Scott Gerst; Matthew Porembka; Peter J Allen; Richard K G Do
Journal:  Clin Imaging       Date:  2016-08-16       Impact factor: 1.605

7.  Loss of Trefoil Factor 2 From Pancreatic Duct Glands Promotes Formation of Intraductal Papillary Mucinous Neoplasms in Mice.

Authors:  Junpei Yamaguchi; Mari Mino-Kenudson; Andrew S Liss; Sanjib Chowdhury; Timothy C Wang; Carlos Fernández-Del Castillo; Keith D Lillemoe; Andrew L Warshaw; Sarah P Thayer
Journal:  Gastroenterology       Date:  2016-08-12       Impact factor: 22.682

Review 8.  [Differentiated therapy for intraductal papillary mucinous neoplasms].

Authors:  M N Wente; B M Schmied; J Schmidt; M W Büchler
Journal:  Chirurg       Date:  2009-01       Impact factor: 0.955

Review 9.  Malignant potential of intraductal papillary mucinous neoplasms of the pancreas.

Authors:  Yoshiyuki Nakajima; Takatsugu Yamada; Masayuki Sho
Journal:  Surg Today       Date:  2010-08-26       Impact factor: 2.549

10.  Loss of Activin Receptor Type 1B Accelerates Development of Intraductal Papillary Mucinous Neoplasms in Mice With Activated KRAS.

Authors:  Wanglong Qiu; Sophia M Tang; Sohyae Lee; Andrew T Turk; Anthony N Sireci; Anne Qiu; Christian Rose; Chuangao Xie; Jan Kitajewski; Hui-Ju Wen; Howard C Crawford; Peter A Sims; Ralph H Hruban; Helen E Remotti; Gloria H Su
Journal:  Gastroenterology       Date:  2015-09-25       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.